These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26077096)

  • 21. Lung abnormalities at multimodality imaging after radiation therapy for non-small cell lung cancer.
    Larici AR; del Ciello A; Maggi F; Santoro SI; Meduri B; Valentini V; Giordano A; Bonomo L
    Radiographics; 2011; 31(3):771-89. PubMed ID: 21571656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cone-beam CT-based delineation of stereotactic lung targets: the influence of image modality and target size on interobserver variability.
    Altorjai G; Fotina I; Lütgendorf-Caucig C; Stock M; Pötter R; Georg D; Dieckmann K
    Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e265-72. PubMed ID: 21620581
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lung deformations and radiation-induced regional lung collapse in patients treated with stereotactic body radiation therapy.
    Diot Q; Kavanagh B; Vinogradskiy Y; Garg K; Gaspar L; Miften M
    Med Phys; 2015 Nov; 42(11):6477-87. PubMed ID: 26520737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter-scan and inter-observer tumour volume delineation variability on cone beam computed tomography in patients treated with stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Hou Y; Lee S; Agrawal V; Romano J; Baldini EH; Chen AB; Kozono DE; Killoran JH; Wagar M; Hacker FL; Aerts HJ; Lewis JH; Mak RH
    J Med Imaging Radiat Oncol; 2017 Feb; 61(1):93-98. PubMed ID: 27709803
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial.
    Sampath S; Rahmanuddin S; Sahoo P; Frankel P; Boswell S; Wong J; Rotter A; Rockne R; Wong J; Park JM
    Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):659-663. PubMed ID: 31271822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of CT lung injury and toxicity after stereotactic radiotherapy delivered with helical tomotherapy in early stage medically inoperable NSCLC.
    Arcangeli S; Agolli L; Portalone L; Migliorino MR; Lopergolo MG; Monaco A; Dognini J; Pressello MC; Bracci S; Donato V
    Br J Radiol; 2015 Apr; 88(1048):20140728. PubMed ID: 25645106
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Early PET-CT After Stereotactic Radiotherapy for Stage 1 Non-small Cell Lung Carcinoma Is Predictive of Local Control.
    Tyran M; Charrier N; Darreon J; Madroszyk A; Tallet A; Salem N
    In Vivo; 2018; 32(1):121-124. PubMed ID: 29275308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volume-based parameters measured by using FDG PET/CT in patients with stage I NSCLC treated with stereotactic body radiation therapy: prognostic value.
    Satoh Y; Onishi H; Nambu A; Araki T
    Radiology; 2014 Jan; 270(1):275-81. PubMed ID: 24029640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in Non-Small Cell Lung Cancer Tumor Location Secondary to Gastric Distension, Implications in the Context of Stereotactic Body Radiation Therapy.
    Gunter T; Arain A; Herman T; Syzek E; Ahmad S; Matthiesen C
    J Okla State Med Assoc; 2015; 108(9-10):398-401. PubMed ID: 26638419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extent and computed tomography appearance of early radiation induced lung injury for non-small cell lung cancer.
    Bernchou U; Christiansen RL; Asmussen JT; Schytte T; Hansen O; Brink C
    Radiother Oncol; 2017 Apr; 123(1):93-98. PubMed ID: 28259449
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiological assessment after stereotactic body radiation of lung tumours.
    Chassagnon G; Martini K; Giraud P; Revel MP
    Cancer Radiother; 2020 Aug; 24(5):379-387. PubMed ID: 32534799
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Distinguishing radiation fibrosis from tumour recurrence after stereotactic ablative radiotherapy (SABR) for lung cancer: a quantitative analysis of CT density changes.
    Mattonen SA; Palma DA; Haasbeek CJ; Senan S; Ward AD
    Acta Oncol; 2013 Jun; 52(5):910-8. PubMed ID: 23106174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Relationship of dose-volume histogram parameters and computed tomography grading of radiation-induced lung injury in patients with non-small cell lung cancer treated by three-dimensional conformal radiotherapy].
    Xing J; Li JB; Yu JM; Lu J; Xu M; Fan TY; Shao Q; Guo SF
    Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):676-81. PubMed ID: 19173909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CT appearance of radiation injury of the lung and clinical symptoms after stereotactic body radiation therapy (SBRT) for lung cancers: are patients with pulmonary emphysema also candidates for SBRT for lung cancers?
    Kimura T; Matsuura K; Murakami Y; Hashimoto Y; Kenjo M; Kaneyasu Y; Wadasaki K; Hirokawa Y; Ito K; Okawa M
    Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):483-91. PubMed ID: 16904838
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relationship between pretreatment FDG uptake and local control after stereotactic body radiotherapy in stage I non-small-cell lung cancer: the preliminary results.
    Hamamoto Y; Sugawara Y; Inoue T; Kataoka M; Ochi T; Takahashi T; Sakai S
    Jpn J Clin Oncol; 2011 Apr; 41(4):543-7. PubMed ID: 21262874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximum standardized uptake value from staging FDG-PET/CT does not predict treatment outcome for early-stage non-small-cell lung cancer treated with stereotactic body radiotherapy.
    Burdick MJ; Stephans KL; Reddy CA; Djemil T; Srinivas SM; Videtic GM
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(4):1033-9. PubMed ID: 20472359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of Local Cancer Recurrence After Stereotactic Ablative Radiation Therapy for Lung Cancer: Physician Performance Versus Radiomic Assessment.
    Mattonen SA; Palma DA; Johnson C; Louie AV; Landis M; Rodrigues G; Chan I; Etemad-Rezai R; Yeung TP; Senan S; Ward AD
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1121-8. PubMed ID: 26907916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential inflammatory response dynamics in normal lung following stereotactic body radiation therapy with protons versus photons.
    Li Y; Dykstra M; Best TD; Pursley J; Chopra N; Keane FK; Khandekar MJ; Sharp GC; Paganetti H; Willers H; Fintelmann FJ; Grassberger C
    Radiother Oncol; 2019 Jul; 136():169-175. PubMed ID: 31015121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomic analysis of planning computed tomograms for predicting radiation-induced lung injury and outcome in lung cancer patients treated with robotic stereotactic body radiation therapy.
    Bousabarah K; Temming S; Hoevels M; Borggrefe J; Baus WW; Ruess D; Visser-Vandewalle V; Ruge M; Kocher M; Treuer H
    Strahlenther Onkol; 2019 Sep; 195(9):830-842. PubMed ID: 30874846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.